Related Articles
Long-term health-related quality of life after curative treatment for prostate cancer: A regional cross-sectional comparison of two standard treatment modalities
Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostate cancer
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression
Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cance
Prognostic value of E‑26 transformation‑specific‑related gene in prostate cancer based on immunohistochemistry analysis